Criterios de diagnóstico y tratamiento | 30 DIC 13

¿Pensó en Polimialgia Reumática?

Una revisión basada en evidencias para la atención primaria sobre un trastorno a menudo subdiagnosticado.
Autor/a: Dres. Sarah L Mackie clinical lecturer, Christian D Mallen BMJ 2013;347:f6937
INDICE:  1.  | 2. Referencias
Referencias

↵Hutchings A, Hollywood J, Lamping DL, Pease CT, Chakravarty K, Silverman B, et al. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. Arthritis Rheum2007;57:803-9.CrossRefMedlineWeb of Science
↵Smeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis2006;65:1093-8.Abstract/FREE Full Text
↵Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum2011;63:633-9.CrossRefMedlineWeb of Science
↵Dasgupta B, Borg FA, Hassan N, Barraclough K, Bourke B, Fulcher J, et al. BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford)2010;49:186-90.FREE Full Text
↵Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis1979;38:434-9.Abstract/FREE Full Text
↵Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis1981;40:1-5.Abstract/FREE Full Text
↵Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med1982;97:672-80.CrossRefMedlineWeb of Science
↵Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum1984;13:322-8.CrossRefMedlineWeb of Science
↵Nobunaga M, Yoshioka K, Yasuda M, Shingu M. Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria. Jpn J Med1989;28:452-6.CrossRefMedline
↵Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis2012;71:484-92.Abstract/FREE Full Text
↵Meliconi R, Pulsatelli L, Uguccioni M, Salvarani C, Macchioni P, Melchiorri C, et al. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum1996;39:1199-207.CrossRefMedlineWeb of Science
↵McGonagle D, Pease C, Marzo-Ortega H, O’Connor P, Gibbon W, Emery P. Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica. J Rheumatol2001;28:1837-41.Abstract/FREE Full Text
↵Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford)2007;46:672-7.Abstract/FREE Full Text
↵Salvarani C, Barozzi L, Cantini F, Niccoli L, Boiardi L, Valentino M, et al. Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis2008;67:758-61.Abstract/FREE Full Text
↵Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, et al. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum2000;30:17-24.CrossRefMedlineWeb of Science
↵Zacharski LR. The erythrocyte sedimentation rate. Br J Hosp Med1976;16:53-62.
↵Hutchinson RM, Eastham RD. A comparison of the erythrocyte sedimentation rate and plasma viscosity in detecting changes in plasma proteins. J Clin Pathol1977;30:345-9.Abstract/FREE Full Text
↵Kanfer EJ, Nicol BA. Haemoglobin concentration and erythrocyte sedimentation rate in primary care patients. J R Soc Med1997;90:16-8.Abstract/FREE Full Text
↵Késmárky G, Kenyeres P, Rábai M, Tóth K. Plasma viscosity: a forgotten variable. Clin Hemorheol Microcirc2008;39:243-6.Medline
↵McCarthy EM, MacMullan PA, Al-Mudhaffer S, Madigan A, Donnelly S, McCarthy CJ, et al. Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica. Rheumatology (Oxford)2013;52:465-71.Abstract/FREE Full Text
↵Weyand CM, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ. Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med1999;159:577-84.CrossRefMedlineWeb of Science
↵Straub RH, Glück T, Cutolo M, Georgi J, Helmke K, Schölmerich J, et al. The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology (Oxford)2000;39:624-31.Abstract/FREE Full Text
↵Olivieri I, Garcia-Porrua C, Padula A, Cantini F, Salvarani C, Gonzalez-Gay MA. Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases. Rheumatol Int2007;27:927-33.CrossRefMedlineWeb of Science
↵Aydeniz A, Altındağ O, Oğüt E, Gürsoy S. Late onset spondyloarthropathy mimicking polymyalgia rheumatica. Rheumatol Int2012;32:1357-8.CrossRefMedline
↵Pego-Reigosa JM, Rodriguez-Rodriguez M, Hurtado-Hernandez Z, Gromaz-Martin J, Taboas-Rodriguez D, Millan-Cachinero C, et al. Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective follow-up study of predictive factors for this condition in patients presenting with polymyalgia symptoms. Arthritis Rheum2005;53:931-8.CrossRefMedlineWeb of Science
↵Falsetti P, Acciai C, Volpe A, Lenzi L. Ultrasonography in early assessment of elderly patients with polymyalgic symptoms: a role in predicting diagnostic outcome? Scand J Rheumatol2011;40:57-63.CrossRefMedline
↵Cantini F, Niccoli L, Storri L, Nannini C, Olivieri I, Padula A, et al. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum2004;33:294-301.CrossRefMedlineWeb of Science
↵Dasgupta B, Borg FA, Hassan N, Alexander L, Barraclough K, Bourke B, et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford)2010;49:1594-7.FREE Full Text
↵Strehl C, Spies CM, Buttgereit F. Pharmacodynamics of glucocorticoids. Clin Exp Rheumatol2011;29(suppl 68):S13-8.Medline
↵Fauchald P, Rygvold O, Oystese B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med1972;77:845-52.CrossRefMedlineWeb of Science
↵Camellino D, Cimmino MA. Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis. Rheumatology (Oxford)2012;51:77-86. Abstract/FREE Full Text
↵Caporali R, Montecucco C, Epis O, Bobbio-Pallavicini F, Maio T, Cimmino MA. Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study. Ann Rheum Dis2001;60:1021-4.Abstract/FREE Full Text
↵Pease CT, Haugeberg G, Morgan AW, M

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022